Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
* First data from late-stage COVID vaccine trial seen in Q4* Q3 product sales $6.52 bln vs consensus $6.50 bln* Q3 profit misses on higher R&D expenses, taxes* 2020 outlook maintained (Writes through, adds executive quote, details on earnings)By Pus...
Read more(Recasts, adds details on vaccine, results, background)Nov 5 (Reuters) - AstraZeneca, the British drugmaker working on one of the world's leading COVID-19 vaccine candidates, beat third-quarter sales estimates on Thursday and reiterated it expects...
Read more(Adds details on earnings, vaccine data)Nov 5 (Reuters) - AstraZeneca, the British drugmaker working on one of the world's leading COVID-19 vaccine candidates, on Thursday beat third-quarter sales estimates as demand for its diverse portfolio of d...
Read more
(Sharecast News) - AstraZeneca said it was on track to meet full-year guidance as the drugs company reported slowing revenue growth in the third quarter.
Read moreNov 5 (Reuters) - AstraZeneca, the British drugmaker working on one of the world's leading COVID-19 vaccine candidates, on Thursday beat third-quarter sales estimates on strong demand for its diverse portfolio of drugs during COVID-19 pandemic lo...
Read more
LONDON MARKET CLOSE: Strong End To Choppy Session On Tight US Poll
Read moreBy Francesco GuarascioBRUSSELS, Nov 4 (Reuters) - Europe's drug regulator will not set a minimum level of efficacy for potential COVID-19 vaccines when considering them for approval, it said on Wednesday, taking a different approach to that of its...
Read more(Sharecast News) - The focus on Thursday will shift to the Bank of England, which is expected to boost the size of its asset purchase facility by £110bn, followed later in the session by the US Federal Reserve which may also signal that further quantitative easing is in the pipeline.
Read moreLONDON MARKET MIDDAY: Stocks In Europe Shake Off US Poll Uncertainty
Read moreLONDON, Nov 4 (Reuters) - British Prime Minister Boris Johnson promised on Wednesday to do whatever it takes to support British businesses and help them bounce back from the coronavirus pandemic."We will do whatever it takes to back British busine...
Read more(Sharecast News) - Doctors in England have been placed on alert for the potential roll-out of a Covid-19 vaccine this side of Christmas.
Read moreLONDON, Nov 4 (Reuters) - Britain's vaccine chief said on Wednesday that she hoped to see positive interim COVID-19 vaccine data from both Oxford and Pfizer and BioNTech in early December allowing a roll out to start this year."If I put on my ros...
Read moreLONDON, Nov 4 (Reuters) - Regulators might approve different coronavirus vaccines candidates at different times but that is not a problem, the chief trial investigator for the shot developed at Oxford University said on Wednesday."I would not imag...
Read more* Oxford trial results due this year - Pollard says* "We are getting closer but not there yet" - Pollard* Britain expects Oxford and Pfizer data in early December* UK vaccine chief: slim chance will wipe out pandemic (Adds context, quotes, writes th...
Read more* Oxford trial results due this year - Pollard says* "We are getting closer but not there yet" - Pollard* Vaccine would be a "game changer" - Pollard* UK expects Oxford and Pfizer data in early December (Adds UK vaccine taskforce chief, PM Johnson)B...
Read more
Last checked at